Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

α-Mangostin can naturally lighten skin by reducing melanin.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Finasteride can cause skin reactions, so dermatologists should be aware.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Gum arabic improves minoxidil delivery to hair follicles, enhancing hair growth.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The FDA approved a new Pfizer drug for hair loss in teens.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Baicalin may help treat severe drug-induced skin reactions.